Sort
261,768 grants matching “gene therapy”
City of Hope Lymphoma SPORE
$2,359,066Stephen J Forma · Beckman Research Institute/City Of Hope · P50 · FY2020 · CA
Creating Comprehensive Maps of Worm and Fly Transcription Factor Binding Sites
$2,358,652Robert H Waterston · University Of Washington · U41 · FY2014 · HG
Immune Cell Interactions in Atherosclerosis
$2,358,435Catherine C Hedrick · Augusta University · P01 · FY2025 · HL
Immune Cell Interactions in Atherosclerosis
$2,358,435Catherine C Hedrick · Augusta University · P01 · FY2023 · HL
Spore in Head and Neck Cancer
$2,358,048David Sidransky · Johns Hopkins University · P50 · FY2008 · DE
Pathobiology of Neurodegeneration in C9ORF72 repeat expansion
$2,357,659Leonard Petrucelli · Mayo Clinic Jacksonville · P01 · FY2021 · NS
Scientific innovation for personalized severe asthma management
$2,357,534Benjamin M Gaston · Indiana University Indianapolis · P01 · FY2024 · HL
LICI Microbiome and Genetics Core
$2,356,885Colm Ohuigin · Division Of Basic Sciences - Nci · ZIC · FY2022 · CA
Skeletal Disorders and Mineral Homeostasis Section
$2,356,702Michael Collins · National Institute Of Dental & Craniofacial Research · ZIA · FY2023 · DE
Loss of VCP Function in Frontotemporal Lobar Degeneration
$2,356,099Edward Byung-Ha Lee · University Of Pennsylvania · RF1 · FY2022 · AG
S.P.O.R.E. in Prostate Cancer
$2,355,770Kenneth J. Pienta · University Of Michigan At Ann Arbor · P50 · FY2006 · CA
Harnessing Mindset in 21st Century Healthcare
$2,355,000Alia Crum · Stanford University · DP2 · FY2016 · AT
Resolving Incomplete Penetrance in the Cardiomyopathies and Channelopathies
$2,355,000Rahul Chandrakant Deo · University Of California, San Francisco · DP2 · FY2013 · HL
Origins of human blood lineages in regenerative medicine
$2,355,000Sean Curtis Bendall · Stanford University · DP2 · FY2016 · EB
Efflux pump inhibitors to reduce duration of antituberculosis therapy
$2,355,000Tawanda Gumbo · Ut Southwestern Medical Center · DP2 · FY2007 · OD
Engineering Morphogenetic Factors for Enhanced Genetic Reprogramming
$2,355,000Charles A Gersbach · Duke University · DP2 · FY2011 · OD
Modulating Eicosanoids to Treat Tuberculosis: Personalized, Host-directed Therapy
$2,355,000David M. Tobin · Duke University · DP2 · FY2011 · OD
Rewiring Control of Leukocyte Motility for Therapeutic Application
$2,355,000Sean Ryan Collins · University Of California At Davis · DP2 · FY2017 · HD
Yale Head and Neck Cancer SPORE: Overcoming Treatment Resistance in Head and Neck Cancer
$2,354,716Barbara Burtness · Yale University · P50 · FY2020 · DE
Molecular Targets Laboratory
$2,354,485James McMahon · Division Of Basic Sciences - Nci · ZIC · FY2017 · CA
Mechanisms and biological consequences of the nuclear receptor CAR activation
$2,354,481Masahiko Negishi · National Institute Of Environmental Health Sciences · ZIA · FY2016 · ES
Chromatin Structure and Gene Expression
$2,354,112Gordon L Hager · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
SPORE in Lung Cancer
$2,353,640John D Minna · Ut Southwestern Medical Center · P50 · FY2007 · CA
Novel Molecular Mechanisms Promote GPCR-Induced Bronchodilation in Asthma
$2,353,263Reynold Alexander Panettieri · University Of Pennsylvania · P01 · FY2015 · HL
Identification of Genes Involved in Major Mood Disorders
$2,353,154Francis J McMahon · National Institute Of Mental Health · ZIA · FY2023 · MH